| Item Type | Name |
|
Concept
|
Antineoplastic Combined Chemotherapy Protocols
|
|
Concept
|
Drug Therapy, Combination
|
|
Concept
|
Chemotherapy, Adjuvant
|
|
Academic Article
|
MYC amplification in breast cancer: a chromogenic in situ hybridisation study.
|
|
Academic Article
|
Topoisomerase II alpha amplification may predict benefit from adjuvant anthracyclines in HER2 positive early breast cancer.
|
|
Academic Article
|
Triple negative breast cancer: molecular profiling and prognostic impact in adjuvant anthracycline-treated patients.
|
|
Academic Article
|
Methylated NEUROD1 promoter is a marker for chemosensitivity in breast cancer.
|
|
Academic Article
|
The prognostic significance of Ki67 before and after neoadjuvant chemotherapy in breast cancer.
|
|
Academic Article
|
Relationship between oestrogen receptor status and proliferation in predicting response and long-term outcome to neoadjuvant chemotherapy for breast cancer.
|
|
Academic Article
|
Down-regulation of the miRNA master regulators Drosha and Dicer is associated with specific subgroups of breast cancer.
|
|
Academic Article
|
Nuclear NF-?B/p65 expression and response to neoadjuvant chemotherapy in breast cancer.
|
|
Academic Article
|
Inference of tumor evolution during chemotherapy by computational modeling and in situ analysis of genetic and phenotypic cellular diversity.
|
|
Academic Article
|
Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial.
|
|
Academic Article
|
PICASSO III: A Phase III, Placebo-Controlled Study of Doxorubicin With or Without Palifosfamide in Patients With Metastatic Soft Tissue Sarcoma.
|
|
Academic Article
|
Treatment of retroperitoneal sarcoma: current standards and new developments.
|
|
Academic Article
|
Clinical and molecular prognostic factors in patients with metastatic colorectal cancer treated with 5-fluorouracil-based chemotherapy.
|
|
Academic Article
|
The development and application of imatinib.
|
|
Academic Article
|
Differential sensitivity of liposarcoma subtypes to chemotherapy.
|
|
Academic Article
|
Neoadjuvant treatment for early-stage breast cancer: opportunities to assess tumour response.
|
|
Academic Article
|
Chemotherapy in clear cell sarcoma.
|
|
Academic Article
|
Clinical benefit of second-line palliative chemotherapy in advanced soft-tissue sarcoma.
|
|
Academic Article
|
Advanced aggressive fibromatosis: Effective palliation with chemotherapy.
|
|
Academic Article
|
Role of palliative chemotherapy in advanced epithelioid sarcoma.
|
|
Academic Article
|
Conventional anthracycline-based chemotherapy has limited efficacy in solitary fibrous tumour.
|
|
Academic Article
|
Current and advancing systemic treatment options for soft tissue sarcomas.
|
|
Academic Article
|
Adult Pleomorphic Rhabdomyosarcoma: A Multicentre Retrospective Study.
|
|
Academic Article
|
Drug repositioning in sarcomas and other rare tumors.
|
|
Academic Article
|
Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial.
|
|
Academic Article
|
Phase III Soft Tissue Sarcoma Trials: Success or Failure?
|
|
Academic Article
|
Neoadjuvant chemotherapy in localised soft-tissue sarcomas: where do we go from here?
|
|
Academic Article
|
Efficacy and safety of trabectedin or dacarbazine in patients with advanced uterine leiomyosarcoma after failure of anthracycline-based chemotherapy: Subgroup analysis of a phase 3, randomized clinical trial.
|
|
Academic Article
|
Doxorubicin plus evofosfamide versus doxorubicin alone in locally advanced, unresectable or metastatic soft-tissue sarcoma (TH CR-406/SARC021): an international, multicentre, open-label, randomised phase 3 trial.
|
|
Academic Article
|
Sarcoma: Does histotype-tailored neoadjuvant therapy improve outcomes?
|
|
Academic Article
|
Anthracycline, Gemcitabine, and Pazopanib in Epithelioid Sarcoma: A Multi-institutional Case Series.
|
|
Academic Article
|
Poor treatment outcomes with palliative gemcitabine and docetaxel chemotherapy in advanced and metastatic synovial sarcoma.
|
|
Academic Article
|
Clinical Characteristics and efficacy of chemotherapy in sclerosing epithelioid fibrosarcoma.
|
|
Academic Article
|
Gemcitabine Re-challenge in Metastatic Soft Tissue Sarcomas: A Therapeutic Option for Selected Patients.
|
|
Academic Article
|
A phase 1 and randomized controlled phase 2 trial of the safety and efficacy of the combination of gemcitabine and docetaxel with ontuxizumab (MORAb-004) in metastatic soft-tissue sarcomas.
|
|
Academic Article
|
Subgroup analysis of older patients treated within the randomized phase 3 doxorubicin versus doxorubicin plus evofosfamide (SARC021) trial.
|
|
Academic Article
|
Probabilistic modeling of personalized drug combinations from integrated chemical screen and molecular data in sarcoma.
|
|
Academic Article
|
Role of Chemotherapy, VEGFR Inhibitors, and mTOR Inhibitors in Advanced Perivascular Epithelioid Cell Tumors (PEComas).
|
|
Academic Article
|
Sarcomas and old age: few options for such a large patient population.
|
|
Academic Article
|
Systemic treatments in MDM2 positive intimal sarcoma: A multicentre experience with anthracycline, gemcitabine, and pazopanib within the World Sarcoma Network.
|
|
Academic Article
|
Adult soft tissue myoepithelial carcinoma: treatment outcomes and efficacy of chemotherapy.
|
|
Academic Article
|
Low-grade Fibromyxoid Sarcoma: Treatment Outcomes and Efficacy of Chemotherapy.
|
|
Academic Article
|
Effect of Doxorubicin Plus Olaratumab vs Doxorubicin Plus Placebo on Survival in Patients With Advanced Soft Tissue Sarcomas: The ANNOUNCE Randomized Clinical Trial.
|
|
Academic Article
|
Health-related quality Of Life In patients with advanced Soft TIssue sarcomas treated with Chemotherapy (The HOLISTIC study): protocol for an international observational cohort study.
|
|
Academic Article
|
Evaluation of the use and efficacy of (neo)adjuvant chemotherapy in angiosarcoma: a multicentre study.
|
|
Academic Article
|
A Timely Oral Option: Single-Agent Vinorelbine in Desmoid Tumors.
|
|
Academic Article
|
Tazemetostat in advanced epithelioid sarcoma with loss of INI1/SMARCB1: an international, open-label, phase 2 basket study.
|
|
Academic Article
|
Efficacy of Gemcitabine-based Chemotherapy in Clear Cell Sarcoma of Soft Tissue.
|
|
Academic Article
|
Future Directions in the Treatment of Osteosarcoma.
|
|
Academic Article
|
Systemic therapies in advanced epithelioid haemangioendothelioma: A retrospective international case series from the World Sarcoma Network and a review of literature.
|
|
Academic Article
|
Pharmacotherapy for liposarcoma: current and emerging synthetic treatments.
|
|
Academic Article
|
Clinicopathological features and treatment outcome of oesophageal gastrointestinal stromal tumour (GIST): A large, retrospective multicenter European study.
|
|
Academic Article
|
Cardiac safety of trabectedin monotherapy or in combination with pegylated liposomal doxorubicin in patients with sarcomas and ovarian cancer.
|
|
Academic Article
|
Gastrointestinal leiomyosarcoma demonstrate a predilection for distant recurrence and poor response to systemic treatments.
|
|
Academic Article
|
Adjuvant Imatinib in Patients with GIST Harboring Exon 9 KIT Mutations: Results from a Multi-institutional European Retrospective Study.
|
|
Academic Article
|
Treatments and Outcomes in Oligometastatic Soft Tissue Soft Sarcoma - A Single Centre Retrospective Analysis.
|
|
Academic Article
|
KIT Exon 9-Mutated Gastrointestinal Stromal Tumours: Biology and Treatment.
|
|
Academic Article
|
Efficacy and Safety of TRC105 Plus Pazopanib vs Pazopanib Alone for Treatment of Patients With Advanced Angiosarcoma: A Randomized Clinical Trial.
|
|
Academic Article
|
Chemotherapy in patients with localized angiosarcoma of any site: A retrospective european study.
|